title: Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.
authors.forename: C R
authors.initials: CR
authors.lastname: MacIntyre
authors.forename: H
authors.initials: H
authors.lastname: Kelly
authors.forename: D
authors.initials: D
authors.lastname: Jolley
authors.forename: H
authors.initials: H
authors.lastname: Butzkueven
authors.forename: D
authors.initials: D
authors.lastname: Salmon
authors.forename: N
authors.initials: N
authors.lastname: Halsey
authors.forename: L H
authors.initials: LH
authors.lastname: Moulton
mesh_terms: D015982:Bias; D016022:Case-Control Studies; D015984:Causality; D003627:Data Interpretation, Statistical; D016208:Databases, Factual / Q000592:standards; D006510:Hepatitis B Antibodies / Q000276:immunology; D017325:Hepatitis B Vaccines / Q000009:adverse effects* / Q000276:immunology; D006515:Hepatitis B virus / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host / Q000187:drug effects / Q000276:immunology; D009103:Multiple Sclerosis / Q000139:chemically induced* / Q000276:immunology / Q000503:physiopathology; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000009:adverse effects* / Q000276:immunology; D015203:Reproducibility of Results; D012189:Retrospective Studies; D006113:United Kingdom
chemical_list: D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D011994:Recombinant Proteins